TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30328210

Group type: EXPERIMENTAL
Intervention: Haemodialysis to Peritoneal Dialysis (HD to PD)
Number of subjects: 911

Group type: COMPARATOR
Intervention: Initiated and remained on Peritoneal Dialysis (PD)
Number of subjects: 911
Study: 29306609

Group type: EXPERIMENTAL
Intervention: MED2005 (0.2% glyceryl trinitrate topical gel)
Number of subjects: 232

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 232
Study: 26439240

Group type: EXPERIMENTAL
Intervention: Clonidine 0.3 mg (oral single dose)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 12
Study: 25271602

Group type: EXPERIMENTAL
Intervention: Introduction of dietary gluten at 6 months (group A)
Number of subjects: 832

Group type: COMPARATOR
Intervention: Introduction of dietary gluten at 12 months (group B)
Number of subjects: 832

Group type: EXPERIMENTAL
Intervention: High-risk HLA genotype
Number of subjects: 832

Group type: COMPARATOR
Intervention: Standard-risk HLA genotype
Number of subjects: 832
Study: 22534709

Group type: EXPERIMENTAL
Intervention: Azithromycin (500 mg qd)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Sulfadiazine and Pyrimethamine
Number of subjects: 19
Study: 19067166

Group type: EXPERIMENTAL
Intervention: Chicago Parent Program (CPP)
Number of subjects: 253

Group type: COMPARATOR
Intervention: Waiting-list control
Number of subjects: 253
Study: 17161554

Group type: EXPERIMENTAL
Intervention: 2-year post-radiotherapy prostate biopsy
Number of subjects: 164
Study: 16447644

Group type: EXPERIMENTAL
Intervention: Direct Laryngoscope (DLS)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Fiberoptic Bronchoscope (FOB)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control (DLS)
Number of subjects: 43
Study: 12540331

Group type: EXPERIMENTAL
Intervention: Daily hypertonic saline nasal irrigation for 6 months
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control group (not specified intervention)
Number of subjects: 76
Study: 9824407

Group type: EXPERIMENTAL
Intervention: Capsaicin spray solution delivering 0.15 mg of capsaicin per nostril once every second or third day for a total of seven treatments.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 8109551

Group type: EXPERIMENTAL
Intervention: 10 mg of benazepril
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 20 mg of benazepril
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 2681393

Group type: EXPERIMENTAL
Intervention: Mebendazole 200 mg
Number of subjects: 568

Group type: COMPARATOR
Intervention: Pyrantel 10 mg/kg
Number of subjects: 568
Study: 772581

Group type: EXPERIMENTAL
Intervention: Methylphenidate hydrochloride (Ritalin) for 60 days
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 31080007

Group type: EXPERIMENTAL
Intervention: Ropivacaine (30mL of 0.375% ropivacaine)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Ropivacaine with Clonidine (30mL of 0.375% ropivacaine with clonidine 1μg.kg‐1)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control (30mL saline)
Number of subjects: 63
Study: 29084663

Group type: EXPERIMENTAL
Intervention: Flurbiprofen axetil
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Parecoxib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Flurbiprofen
Number of subjects: 0
Study: 25880822

Group type: EXPERIMENTAL
Intervention: Skin-to-skin contact for 60 minutes, twice a day for 7 days
Number of subjects: 102

Group type: COMPARATOR
Intervention: Routine care without skin-to-skin contact
Number of subjects: 102
Study: 23994975

Group type: EXPERIMENTAL
Intervention: Left cardiac catheterization
Number of subjects: 167

Group type: COMPARATOR
Intervention: Multidetector computed tomography (MDCT)
Number of subjects: 167
Study: 21430518

Group type: EXPERIMENTAL
Intervention: Low tidal volume ventilation (6 ml/kg)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Control group (10 ml/kg tidal volume)
Number of subjects: 149
Study: 19132780

Group type: EXPERIMENTAL
Intervention: Specific neck stabilization exercises with general neck advice and exercise program
Number of subjects: 74

Group type: COMPARATOR
Intervention: General neck advice and exercise program alone
Number of subjects: 74
Study: 17499444

Group type: EXPERIMENTAL
Intervention: Physical activity counseling (exercise group)
Number of subjects: 299

Group type: COMPARATOR
Intervention: Health education advice (control group)
Number of subjects: 299
Study: 15501201

Group type: EXPERIMENTAL
Intervention: 1.5 g/d of glucosamine (n = 101)
Number of subjects: 205

Group type: COMPARATOR
Intervention: Placebo (n = 104)
Number of subjects: 205
Study: 10831989

Group type: EXPERIMENTAL
Intervention: Oral misoprostol (100 microgram)
Number of subjects: 236

Group type: COMPARATOR
Intervention: Vaginal misoprostol (25 microgram)
Number of subjects: 236
Study: 9180103

Group type: EXPERIMENTAL
Intervention: E6010 (0.22 mg/kg body weight intravenously over 2 min)
Number of subjects: 199

Group type: COMPARATOR
Intervention: Native t-PA (28.8 mg or 14.4 million IU, 10% over 1 to 2 min, remainder over 60 min)
Number of subjects: 199
Study: 8267066

Group type: EXPERIMENTAL
Intervention: 2.5 mg of oral slow‐release isradipine twice a day
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: 250 mg of methyldopa three times a day
Number of subjects: 42

Group type: COMPARATOR
Intervention: 5 mg of oral slow‐release isradipine twice a day
Number of subjects: 42

Group type: COMPARATOR
Intervention: Matched controls without medication
Number of subjects: 42
Study: 3749828

Group type: COMPARATOR
Intervention: Lidocaine 1% (2 ml)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Diclofenac (Voltaren) (50 mg, 2 ml)
Number of subjects: 24
Study: 30915663

Group type: COMPARATOR
Intervention: RT-HIIT
Number of subjects: 206

Group type: COMPARATOR
Intervention: AT-HIIT
Number of subjects: 206
Study: 28801938

Group type: EXPERIMENTAL
Intervention: Gabapentin 1500 mg/day
Number of subjects: 83
Study: 25938296

Group type: EXPERIMENTAL
Intervention: Robotic telerounding (RP-7 robot)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional telephone rounds
Number of subjects: 20
Study: 23468980

Group type: EXPERIMENTAL
Intervention: Adjuvant iodine-125 brachytherapy
Number of subjects: 68

Group type: COMPARATOR
Intervention: Best care (control)
Number of subjects: 68
Study: 21527583

Group type: EXPERIMENTAL
Intervention: TGFB1 (rs1982073)
Number of subjects: 6703

Group type: EXPERIMENTAL
Intervention: TGFBR1 (rs10512263)
Number of subjects: 6703

Group type: EXPERIMENTAL
Intervention: TGFBR2 (rs4522809)
Number of subjects: 6703

Group type: COMPARATOR
Intervention: Endothelial-specific pathway SNPs (ALK1/SMADs 1&5)
Number of subjects: 6703
Study: 18054611

Group type: EXPERIMENTAL
Intervention: Magnesium sulfate (MgSO4) therapy
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study: 16529338

Group type: EXPERIMENTAL
Intervention: Pharmacist-guided education and monitoring (PGEM)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 60
Study: 14633803

Group type: EXPERIMENTAL
Intervention: New Dietary Education (NDE) program
Number of subjects: 173

Group type: COMPARATOR
Intervention: Control (conventional dietary education)
Number of subjects: 173
Study: 10566918

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 40

Group type: COMPARATOR
Intervention: Isoflurane
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study: 8750483

Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT) for at least one year
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not receiving HRT
Number of subjects: 0
Study: 2049556

Group type: EXPERIMENTAL
Intervention: Ketoconazole (K)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 125
Study: 6124261

Group type: EXPERIMENTAL
Intervention: Diphenylhydantoin
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Pyrroxan
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 31856747

Group type: EXPERIMENTAL
Intervention: Infant food hygiene intervention targeting caregiver behaviours (hand washing, boiling food, storing food in sealed containers, using specific utensils)
Number of subjects: 750

Group type: EXPERIMENTAL
Intervention: Infant food hygiene intervention
Number of subjects: 750
Study: 27893032

Group type: EXPERIMENTAL
Intervention: Individual Cognitive Processing Therapy (CPT) - 60-minute sessions, twice weekly for 6 weeks
Number of subjects: 268

Group type: COMPARATOR
Intervention: Group Cognitive Processing Therapy (CPT) - 90-minute sessions, twice weekly for 6 weeks
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: Both formats (Individual and Group CPT)
Number of subjects: 268
Study: 27813396

Group type: EXPERIMENTAL
Intervention: Stapled anopexy (SA)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Transanal hemorrhoidal dearterialization (THD)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Both techniques (SA and THD)
Number of subjects: 70
Study: 24850844

Group type: EXPERIMENTAL
Intervention: Regular booster immunizations every 2 weeks (arm 1)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Personalized schedules of immunization determined using real-time immune monitoring (arm 2)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Both arms (1 and 2)
Number of subjects: 16
Study: 22253758

Group type: EXPERIMENTAL
Intervention: Brain Age
Number of subjects: 32

Group type: COMPARATOR
Intervention: Tetris
Number of subjects: 32
Study: 20883232

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 200
Study: 17389458

Group type: EXPERIMENTAL
Intervention: Growth Hormone (GH) therapy, mean dose 0.16±0.06 mg/day
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 16147225

Group type: EXPERIMENTAL
Intervention: Voice course (8 consecutive sessions)
Number of subjects: 16
Study: 11952543

Group type: EXPERIMENTAL
Intervention: Single consultation with a primary care nurse for 30 minutes
Number of subjects: 235

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 235
Study: 9440387

Group type: EXPERIMENTAL
Intervention: MUFA diet
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 100
Study: 8570366

Group type: EXPERIMENTAL
Intervention: Positive attitude toward speech
Number of subjects: 40

Group type: COMPARATOR
Intervention: Neutral attitude toward speech
Number of subjects: 40
Study: 2001087

Group type: EXPERIMENTAL
Intervention: Propafenone (300 mg three times daily in 19 patients, 300 mg twice daily in 3 patients, and 150 mg twice daily in 1 patient)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 6340806

Group type: EXPERIMENTAL
Intervention: Timolol 0.5% eye drops after placebo or 80 mg propranolol
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Timolol 0.5% eye drops after 160 mg propranolol
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Timolol 0.5% eye drops after 120 mg propranolol
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Propranolol 80 mg
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Propranolol 160 mg
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Propranolol 120 mg
Number of subjects: 19
Study: 30817752

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for child SepAD (TAFF or CC)
Number of subjects: 107

Group type: COMPARATOR
Intervention: No treatment (Control group)
Number of subjects: 107
Study: 30256184

Group type: EXPERIMENTAL
Intervention: Problem-Solving Education (PSE)
Number of subjects: 223

Group type: COMPARATOR
Intervention: Usual services (Control)
Number of subjects: 223
Study: 25547036

Group type: EXPERIMENTAL
Intervention: Obstructive sleep apnea (OSA) defined as an apnea-hypopnea-index (AHI) ≥15 events/h
Number of subjects: 431

Group type: COMPARATOR
Intervention: No obstructive sleep apnea (no OSA) defined as an AHI <5
Number of subjects: 431

Group type: EXPERIMENTAL
Intervention: Obstructive sleep apnea (OSA)
Number of subjects: 431
Study: 23834227

Group type: EXPERIMENTAL
Intervention: CBT + ATS (n = 29)
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: CBT + ETS (n = 41)
Number of subjects: 173

Group type: COMPARATOR
Intervention: Waitlist control (n = 103)
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: CBT + ATS (n = 39) at follow-up
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: CBT + ETS (n = 64) at follow-up
Number of subjects: 173
Study: 21305227

Group type: EXPERIMENTAL
Intervention: Botulinum toxin A
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study: 19506295

Group type: EXPERIMENTAL
Intervention: Active consent procedures
Number of subjects: 14

Group type: COMPARATOR
Intervention: Passive consent procedures
Number of subjects: 14
Study: 16815260

Group type: EXPERIMENTAL
Intervention: Short questionnaire for dry eye syndrome (DES)
Number of subjects: 690
Study: 15124838

Group type: EXPERIMENTAL
Intervention: Heated, water-filled mattress (HWM)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Incubator care
Number of subjects: 74
Study: 11215748

Group type: EXPERIMENTAL
Intervention: Octreotide (0.1 mg subcutaneously three times a day)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control (conservative treatment only)
Number of subjects: 50
Study: 8628802

Group type: EXPERIMENTAL
Intervention: Textured implants
Number of subjects: 61

Group type: COMPARATOR
Intervention: Smooth-walled implants
Number of subjects: 61
Study: 1728731

Group type: EXPERIMENTAL
Intervention: Preoperative antibiotics
Number of subjects: 2847

Group type: EXPERIMENTAL
Intervention: Perioperative antibiotics
Number of subjects: 2847

Group type: EXPERIMENTAL
Intervention: Postoperative antibiotics
Number of subjects: 2847

Group type: EXPERIMENTAL
Intervention: Early antibiotics (2 to 24 hours before incision)
Number of subjects: 2847
Study: 6142643

Group type: EXPERIMENTAL
Intervention: diazepam 10 mg in its commercially available form
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: diazepam 10 mg masked in opaque capsules
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: hydroxyzine pamoate 50 mg in its commercially available form
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: hydroxyzine pamoate 50 mg masked in opaque capsules
Number of subjects: 120

Group type: COMPARATOR
Intervention: anxiety scores
Number of subjects: 120

Group type: COMPARATOR
Intervention: previous drug therapy
Number of subjects: 120
Study: 30782895

Group type: EXPERIMENTAL
Intervention: Biofeedback-mediated pelvic floor muscle training (PFMT)
Number of subjects: 600

Group type: COMPARATOR
Intervention: Pelvic floor muscle training (PFMT)
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Biofeedback-mediated PFMT
Number of subjects: 600

Group type: COMPARATOR
Intervention: PFMT
Number of subjects: 600
Study: 29338782

Group type: EXPERIMENTAL
Intervention: Video group
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Booklet group
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Video group vs Booklet group
Number of subjects: 200
Study: 26980878

Group type: EXPERIMENTAL
Intervention: Social media intervention to promote HIV testing
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison communities (control)
Number of subjects: 0
Study: 24625508

Group type: COMPARATOR
Intervention: Clinically driven monitoring (CDM)
Number of subjects: 2317

Group type: EXPERIMENTAL
Intervention: Routine laboratory and clinical monitoring (LCM)
Number of subjects: 2317

Group type: EXPERIMENTAL
Intervention: Second-line therapy
Number of subjects: 2317

Group type: EXPERIMENTAL
Intervention: First-line therapy
Number of subjects: 2317
Study: 22727286

Group type: EXPERIMENTAL
Intervention: Vitrectomy and gas tamponade
Number of subjects: 98

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 98
Study: 20847066

Group type: EXPERIMENTAL
Intervention: Tumescent anesthesia before and continuously during EVLT (Group B)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Classical tumescent anesthesia before ablation (Group A)
Number of subjects: 25
Study: 17592197

Group type: EXPERIMENTAL
Intervention: DDIR mode
Number of subjects: 24

Group type: COMPARATOR
Intervention: DDDR mode
Number of subjects: 24
Study: 15660075

Group type: EXPERIMENTAL
Intervention: Rofecoxib 50 mg po preoperatively and Dexamethasone 10 mg IV intraoperatively
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo po preoperatively and Placebo IV intraoperatively
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Rofecoxib 50 mg po preoperatively
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Placebo po preoperatively and Dexamethasone 10 mg IV intraoperatively
Number of subjects: 29
Study: 11873024

Group type: EXPERIMENTAL
Intervention: Ropivacaine, 0.75% (n = 10)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Bupivacaine, 0.75% (n = 10)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Both ropivacaine and bupivacaine
Number of subjects: 20
Study: 10100362

Group type: EXPERIMENTAL
Intervention: Irrigating fluids containing glycine, mannitol, and sorbitol infused at 0.75 ml/kg/min for 20 min
Number of subjects: 10
Study: 9878638

Group type: EXPERIMENTAL
Intervention: Minocycline and rifampin impregnated catheters
Number of subjects: 865

Group type: COMPARATOR
Intervention: Chlorhexidine and silver sulfadiazine impregnated catheters
Number of subjects: 865
Study: 2238575

Group type: EXPERIMENTAL
Intervention: High-dose intravenous immunoglobulin (IVIG) therapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 328244

Group type: EXPERIMENTAL
Intervention: Amantadine HC1 (Symmetrel)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 31090087

Group type: EXPERIMENTAL
Intervention: IPL and CO2 ablative fractional laser (AFL)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: CO2 AFL alone
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control (no laser treatment)
Number of subjects: 23
Study: 28545482

Group type: EXPERIMENTAL
Intervention: pioglitazone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: single-arm trial
Number of subjects: 0

Group type: COMPARATOR
Intervention: randomized controlled trial
Number of subjects: 0
Study: 26419795

Group type: EXPERIMENTAL
Intervention: Yoga intervention (8 weeks)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (n = 20)
Number of subjects: 20
Study: 23786821

Group type: EXPERIMENTAL
Intervention: Buttermilk (45 g/d)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo (45 g/d)
Number of subjects: 34
Study: 21801508

Group type: EXPERIMENTAL
Intervention: Acupuncture (≥12 sessions of five-element acupuncture)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control (usual care, starting after 26 weeks)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 80

Group type: COMPARATOR
Intervention: Acupuncture and Control
Number of subjects: 80
Study: 19254438

Group type: EXPERIMENTAL
Intervention: Dynamic psychotherapy with moderate level of transference interpretations
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Dynamic psychotherapy without transference interpretations
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Dynamic psychotherapy with transference interpretations
Number of subjects: 100
Study: 17001071

Group type: EXPERIMENTAL
Intervention: Zoledronic acid (4 mg) administered monthly for 3 months
Number of subjects: 31
Study: 15253688

Group type: EXPERIMENTAL
Intervention: Alefacept (12 weekly injections followed by 12 treatment-free weeks)
Number of subjects: 1300

Group type: EXPERIMENTAL
Intervention: Alefacept (subsequent courses)
Number of subjects: 1300

Group type: EXPERIMENTAL
Intervention: Alefacept (multiple courses)
Number of subjects: 1300

Group type: EXPERIMENTAL
Intervention: Alefacept
Number of subjects: 1300
Study: 11687526

Group type: EXPERIMENTAL
Intervention: Topical timolol
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 9456560

Group type: EXPERIMENTAL
Intervention: Artificial Neural Networks (ANN) for analysis of visual evoked potentials (VEP)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Visual evoked potentials (VEP) analysis
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Artificial Neural Networks (ANN)
Number of subjects: 96
Study: 7928930

Group type: EXPERIMENTAL
Intervention: Multidisciplinary education protocol delivered by GPs, community nurses, asthma nurses, and doctors consisting of 16 educational modules.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multidisciplinary education protocol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 3789237

Group type: EXPERIMENTAL
Intervention: Denver Developmental Screening Test (DDST) with community health intervention program for positive screenees
Number of subjects: 4797

Group type: EXPERIMENTAL
Intervention: Denver Developmental Screening Test (DDST) with no intervention for positive screenees
Number of subjects: 4797

Group type: COMPARATOR
Intervention: No screening test
Number of subjects: 4797

Group type: EXPERIMENTAL
Intervention: Intervention program children
Number of subjects: 4797

Group type: EXPERIMENTAL
Intervention: Children with positive preschool DDSTs
Number of subjects: 4797
Study: 30249211

Group type: EXPERIMENTAL
Intervention: Nivolumab monotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination nivolumab/ipilimumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard of care neoadjuvant radiation therapy
Number of subjects: 0
Study: 26147943

Group type: EXPERIMENTAL
Intervention: Evidence supported smoking cessation therapy (including pharmacotherapy and behavioral support)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Smoking behaviors and motivations for quitting
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Previous attempts to stop smoking
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Future recommendations
Number of subjects: 0
Study: 25748868

Group type: EXPERIMENTAL
Intervention: Proxy consent from next of kin (NOK)
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Consent from general practitioner (GP)
Number of subjects: 171
Study: 23102691

Group type: EXPERIMENTAL
Intervention: Cognitive remediation
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 42